Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/8/25 17:08 | 1/7/25 | BGNE | Health | Drug | Pharmaceutical Preparations | Wang Xiaodong | E9 | DH | Chair, S | 6 | M.d | 25,159 | 99.11 | 0 | 254 | 3 | 10,325 | D | ||||||||||||||
1/8/25 17:08 | 1/7/25 | BGNE | Health | Drug | Pharmaceutical Preparations | Wang Xiaodong | E9 | DH | Chair, S | 6 | S.d | -25,159 | 99.11 | 0 | -254 | 10,325 | D | |||||||||||||||
12/17/24 17:02 | 12/14/24 | BGNE | Health | Drug | Pharmaceutical Preparations | Oyler John | E9 | DO | CEO | 1 | M.d | 650 | 0.5000 | 0 | 1,300 | 3 | 49,040 | D | ||||||||||||||
12/10/24 21:25 | 12/9/24 | BGNE | Health | Drug | Pharmaceutical Preparations | Baker Bros. Advisors LP | NY | D | 1 | S | -194,200 | 187.27 | 0 | -1,037 | 9,013 | I | ||||||||||||||||
12/10/24 20:19 | 12/6/24 | BGNE | Health | Drug | Pharmaceutical Preparations | Wu Xiaobin | E9 | O | P,COO,GM | 1 | S | 0 | 0.00 | 0 | 0 | 0 | 1,088 | I | ||||||||||||||
12/4/24 16:06 | 12/2/24 | BGNE | Health | Drug | Pharmaceutical Preparations | Hhlr Advisors, Ltd. | E9 | T | 1 | S | -2,147,484 | 120.36 | 0 | -17,843 | 125,046 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |